// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Cryptococcus infections in cardiothoracic transplant recipients – a variable journey

Roopam Sehajpal - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Single centre lung transplant experience of customised biodegradable stents in the early post-lung transplant period

Kavita Dave - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Cystic Fibrosis

N/A

Interferon gamma (IFN?) pathway deficiency and severe NTM disease

Shashank Sharma - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Interferon Gamma

Bedaquiline in the treatment of multi-drug resistant non-tuberculous mycobacteria soft tissue infections: a case series

Francesca Wright - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Bedaquiline

Sputum proteomics of CF, BE and COPD with or without NTM infections

Rebecca Hull - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

The non-tuberculous pulmonary disease experience in a general respiratory clinic in the UK

Yadee Maung Maung Myint - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

Chronic obstructive pulmonary disease

N/A

A data-driven approach to identify putative tuberculosis among adolescents in resource-constrained settings

Siyanai Zhou - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Impact of COVID-19 on TB management in an East London Hospital

Ananna Rahman - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Management of ocular tuberculosis(OTB): The role of CT and Positron Emission Tomography(PET) imaging

Kavina Manalan - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Availability of drug susceptibility testing to new/re-purposed anti-tuberculosis drugs: a TBnet study

Lorenzo Guglielmetti - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

Bedaquiline

Identification of isoniazid mono-resistance is delayed despite whole genome sequencing

Mirae Park - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Isoniazid

Barriers and enablers to implementing TB control strategies in EU and EEA countries: a systematic review

Olivia Conroy - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Impact of the SARS-CoV-2 pandemic on incidence and phenotype of tuberculosis in a UK hotspot

Jee Whang Kim - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Tuberculosis

N/A

Effect on length of stay in a district general hospital after respiratory led pleural interventions

Samir Naik - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Thoracic Ultrasound for guiding pleurodesis in malignant pleural effusion: a randomised trial

Maged Hassan - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Assessing the diagnostic accuracy of ultrasound-guided percutaneous cutting-needle pleural biopsy - A systematic review and meta-analysis

Michael Pace Bardon - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

COVID-19 advanced respiratory physiology (CARP) wearable respiratory monitoring: early insights

Stephanie Lua - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Self reported impacts of remote monitoring in England during COVID-19

Helen Parrott - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Self-reported usability and acceptability of using virtual consultations (VCs) during and after COVID-19 pandemic in the UK

Nasir Majeed - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

Coronavirus disease

N/A

Dynamic Early Warning Score versus National Early Warning Score-2 for predicting death or intensive care unit admission in respiratory patients

Sherif Gonem - European Respiratory Society (ERS) , 2021

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved